Incidence of symptomatic stroke and cancer in chronic kidney disease patients treated with epoetins

Clinical and Experimental Nephrology

Volumn 14, Issue 5, 2010, Pages 445-452

  Imai, Enyu ^a   Yamamoto, Ryohei ^b   Suzuki, Hiromichi ^c   Watanabe, Tsuyoshi ^d  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer; CKD; Japanese; Renal anemia; Stroke

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION;

AGED; CROSS-SECTIONAL STUDIES; EPOETIN ALFA; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RENAL INSUFFICIENCY, CHRONIC; STROKE;

EID: 78149411236     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0308-x     Document Type: Article

References (19)

1. D Sliverberg D Wexler M Blum, et al. 2003 The cardio-renal-anemia syndrome: does it exist? Nephrol Dial Transplant 18 Supple 8 viii7 viii12
2. F Locatelli RL Pisoni C Combe J Bommer VE Andreucci L Piera, et al. 2004 Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol Dial Transplant 19 1 121 132 10.1093/ndt/gfg458 14671047 (Pubitemid 38072623)
3. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre 1996 The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1 53 61 1:STN:280:DyaK28zht1eqsg%3D%3D 10.1016/S0272-6386(96)90130-4 8712222
4. JSDT 2008 Guideline for renal anemia in chronic kidney disease Japanese of Japanese Society for Dialysis Therapy 41 661 716 10.4009/jsdt.41.661
5. European Best Practice guideline working group 2004 European best practice guideline for the management of anemia in patients with chronic renal failure Nephrol Dial Transplant 19 Supple 2 S1 S47
6. KDOQI 2006 Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease Am J Kidney Dis 47 Supple 3 S1 S144
7. MA Pfeffer EA Burdmann CY Chen ME Cooper D de Zeeuw KU Eckardt, et al. 2009 A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2019 2032 10.1056/NEJMoa0907845 19880844
8. E Imai M Horio T Watanabe K Iseki K Yamagata S Hara, et al. 2009 Prevalence of chronic kidney disease in the Japanese general population Clin Exp Nephrol 13 621 630 10.1007/s10157-009-0199-x 19513802
9. S Matsuo E Imai M Horio, et al. 2009 Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 6 982 992 1:CAS:528: DC%2BD1MXnslKku7c%3D 10.1053/j.ajkd.2008.12.034 19339088
10. J Cuzick 1985 A Wilcoxon-type test for trend Stat Med 4 1 87 90 1:STN:280:DyaL2M7pt1Sntw%3D%3D 10.1002/sim.4780040112 3992076
11. Prevalence of stroke in Japanese general population. http://www.mhlw.go. jp/toukei/kouhyo/data-kou18/data12/junkan-h12-2.pdf. Accessed 25 April 2010.
12. Y Kokubo S Nakamura T Okamura Y Yoshimasa H Makino M Watanabe, et al. 2009 Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study Stroke 40 8 2674 2679 10.1161/STROKEAHA.109. 550707 19478215
13. R Inoue T Ohkubo M Kikuya H Metoki K Asayama A Kanno, et al. 2009 Stroke risk of blood pressure indices determined by home blood pressure measurement: the Ohasama study Stroke 40 8 2859 2861 10.1161/STROKEAHA.108.546499 19478224
14. AK Singh L Szczech KL Tang H Barnhart S Sapp M Wolfson, et al. 2006 Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 20 2085 2098 1:CAS:528:DC%2BD28Xht1Wqt7fN 10.1056/NEJMoa065485 17108343 (Pubitemid 44749317)
15. TB Drüeke F Locatelli N Clyne KU Eckardt IC Macdougall D Tsakiris, et al. 2006 Normalization of hemoglobin level in patients with chronic kidney disease and anemia N Engl J Med 355 20 2071 2084 10.1056/NEJMoa062276 17108342 (Pubitemid 44749316)
16. JW Eschbach MH Abdulhadi JK Browne BG Delano MR Downing JC Egrie, et al. 1989 Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Intern Med 111 12 992 1000 1:STN:280:DyaK3c%2FoslCquw%3D%3D 2688507
17. Canadian Erythropoietin Study Group 1990 Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis Br Med J 300 6724 573 578 10.1136/bmj.300.6724.573
18. LA Szczech HX Barnhart JK Inrig DN Reddan S Sapp RM Califf, et al. 2008 Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes Kidney Int 74 6 791 798 1:CAS:528:DC%2BD1cXhtVGgtbjN 10.1038/ki.2008.295 18596733
19. H Hirakata Y Tsubakihara F Gejyo S Nishi Y Iino Y Watanabe, et al. 2010 Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Clin Exp Nephrol 14 1 28 35 1:CAS:528:DC%2BC3cXltVajsbg%3D 10.1007/s10157-009- 0212-4 19763743